Prothena Corp Public (PRTA) Return on Sales (2013 - 2026)

Prothena Corp Public's Return on Sales history runs 14 years deep, the most recent figure standing at 0.01% for Q1 2026.

• In Q1 2026, Return on Sales rose 22.0% year-over-year to 0.01%; the TTM figure through Mar 2026 stood at 0.03% (down 2.0% YoY), while the FY2025 annual figure was 0.25%, down 24.0% from the prior year.
• Return on Sales was 0.01% for Q1 2026 at Prothena Corp Public, up from 10.28% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.01% in Q1 2026 to a low of 14.45% in Q1 2024.
• Historically, Return on Sales has averaged 1.74% across 5 years, with a median of 0.27% in 2024.
• The sharpest annual moves came in 2024 and 2025: Return on Sales plunged 1423 bps in 2024, then soared 1424 bps in 2025.
• A 5-year view of Return on Sales shows it stood at 0.0% in 2022, then tumbled by 167978 bps to 2.13% in 2023, then jumped by 87 bps to 0.27% in 2024, then sank by 3664 bps to 10.28% in 2025, then surged by 100 bps to 0.01% in 2026.
• The last three Return on Sales figures came in at 0.01% (Q1 2026), 10.28% (Q4 2025), and 0.15% (Q3 2025), per Business Quant data.